More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
Sotagliflozin Gets FDA's Blessing for Heart Failure SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
Oral Semaglutide Sheds Pounds; USPSTF Taking Obesity Comments; Plant Extract for T2D News and commentary from the endocrinology world May 23, 2023
Obesity Drug's Mid-Stage Win; Endocrine Disease Disparities; Chewing Away Diabetes? News and commentary from the endocrinology world May 16, 2023
Topical Esmolol Gel Helped Heal Diabetic Foot Ulcers Significantly better than standard of care at 12 and 24 weeks May 15, 2023
Senators Call Out PBMs, Drugmakers for High Prescription Drug Costs This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
Novel Drug Fails to Improve Diabetic Retinopathy, but Slows Progression Significantly fewer patients had 3-step worsening of DRSS with oral antiangiogenic May 09, 2023
Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however May 08, 2023
GLP-1 RAs Safe Months After Kidney Transplant Helped diabetics cut down on daily insulin dose, body weight May 08, 2023
Is Electrical Duodenal Resurfacing the Next Big Thing for T2D and Obesity? Small trials show big boost in insulin sensitivity, plus weight loss May 07, 2023
Vascular Complications Big Contributor to Diabetes Deaths Diabetic nephropathy was most common of the fatal complications, study showed May 05, 2023
Patients Shed 15% of Body Weight With Tirzepatide, Drugmaker Says With findings from SURMOUNT-2, Eli Lilly plans to finish FDA submission Apr 27, 2023
Bariatric-Metabolic Surgery More Effective Than Lifestyle Change for NASH Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis Apr 26, 2023
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram? News and commentary from the endocrinology world Apr 25, 2023
New Reader for FreeStyle Libre 3; COVID Bumps Diabetes Risk; Tepezza Label Expanded News and commentary from the endocrinology world Apr 18, 2023
'Relaxed' A1c OK for Mitigating Dementia Risk in Older Diabetes Patients Keeping most readings under 9% avoided elevated dementia risk Apr 17, 2023
Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
Certain Painkillers Linked to Heart Failure in Type 2 Diabetes Population-based study shows older patients with poorly controlled diabetes at particular risk Apr 10, 2023
Diabetes Patient Develops Large Blisters, Macules on Lower Leg Is infection, injury, or diabetic dermopathy responsible? Apr 10, 2023
Physicians Struggle to Help Diabetes Patients Get Tirzepatide Popular drug faces supply problems and increased demand Apr 07, 2023
Can COVID Lead to Diabetes? Early work suggests a connection, but experts say more investigation is needed Mar 29, 2023
Higher Rybelsus Doses More Effective; Insulin Cap for All? Win for GLP-1/GIP Drug News and commentary from the endocrinology world Mar 28, 2023
Reversing Prediabetes Alone Doesn't Cut Mortality Risk Reduced risk only seen in physically active patients, Taiwanese study found Mar 28, 2023
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients But do these initiatives work? Mar 26, 2023
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat? News and commentary from the endocrinology world Mar 21, 2023
Why Does Insulin Cost So Much? Big Pharma Isn't the Only Player Driving Prices Casting a light on profiteering methods of price mediators Mar 12, 2023
Are High Costs of Newer Diabetes Drugs Deterring Eligible Patients? Data show most eligible patients are not using GLP-1 receptor agonists or SGLT2 inhibitors Feb 27, 2023
Zero-Cal Sweetener Erythritol Disappoints on Cardiovascular Safety Keto-friendly food additive carries unknown long-term health effects Feb 27, 2023
Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit News and commentary from the endocrinology world Feb 21, 2023
Old Drug May Help Protect People With Diabetes Against Dementia Those with history of ischemic heart disease or stroke saw greatest protection with pioglitazone Feb 15, 2023
Does COVID Vaccine Blunt Elevated Diabetes Risk After Infection? Unvaccinated had a 78% higher risk for new-onset diabetes; no link seen among the vaccinated Feb 14, 2023
Lower Blood Pressure Better in Pregnancy With Diabetes Going even lower on blood pressure appeared to help in a secondary trial analysis Feb 13, 2023
Phthalates Exposure Tied to Higher Incidence of Type 2 Diabetes in White Women But possible selection bias may have negated this risk in women of color, researchers say Feb 08, 2023
No Visual Acuity Benefit With Early Anti-VEGF for Diabetic Retinopathy "May not be worth the risk and inconvenience to the patient," researcher says Feb 07, 2023
Can High-Dose Vitamin D Prevent Diabetes? While three trials found no net benefit, combining them yielded significant risk reduction Feb 06, 2023
ED Screening Program Picks Up Lots of Undiagnosed Diabetes Cases EHR alerts at Chicago ED flagged about three in 10 at-risk patients for HbA1c testing Jan 26, 2023
Over 1 Million Medicare Beneficiaries Will Pocket Savings From Insulin Cap Report uses 2020 claims data to estimate potential effects of IRA's $35 monthly insulin cap Jan 24, 2023
